We also demonstrate that saRNA-induced upregulation of CEBPA sensitizes a well-characterized, FLT3-ITD+ AML line, MOLM-14 AML cells, to FLT3 inhibition. This evidence concerns the gene CEBPA and acute myeloid leukemia.